# SiriusPoint Ltd. (SPNT)

> Source: Nexqual · https://nexqual.com/SPNT · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, SiriusPoint Ltd. (SPNT), nexqual.com/SPNT" · informational, not investment advice.

**Price:** USD 25.96 (+1.09% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 25.68 · day 25.48–26.11 · 52w 17.71–26.5 · market cap $3.02B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $3.25B, net income $506M (15.6% margin) (SEC filings).
- Valuation: P/E 6.0x (avg 8.4x at the last 3 fiscal year-ends), net debt $60.7M.
- Analysts: Buy (mean 2.20 on a 1–5 scale) (5 analysts), mean target USD 28.75 (range 27–31).
- Total return with dividends: 1Y +41.3% vs S&P 500 +14.9%; 5Y +175.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 0.64, revenue estimate $783M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.18B | $2.11B | $2.74B | $2.60B | $3.21B | $3.25B |
| Net income | $58.1M | -$387M | $355M | $200M | $460M | $506M |
| EPS (diluted) | $0.27 | -$2.51 | $1.85 | $1.04 | $3.64 | — |
| Net margin | 2.7% | -18.4% | 13.0% | 7.7% | 14.3% | 15.6% |
| Revenue growth | +145.1% | -3.4% | +30.0% | -4.9% | +23.1% | — |
| Cash + short-term investments | $1000M | $705M | $969M | $682M | $731M | — |
| Total debt | $817M | $778M | $786M | $639M | $689M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 6.0x · P/S 0.9x · EV/Sales 0.9x · P/B 1.3x · Earnings yield 16.77% · Dividend yield (paid, TTM) 0.00% · Buyback yield (TTM) 2.43% · Net debt $60.7M · EV $3.08B
P/E at fiscal year-ends: Dec 2025 5.8x, Dec 2024 13.9x, Dec 2023 5.5x.

## Analysts
Consensus Buy (mean 2.20 on a 1–5 scale), 5 analysts; mean target USD 28.75 (low 27, high 31).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-22 | RBC Capital | Initiated | Outperform | $30 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +41.3% | +175.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +41.5% | +22.4% |
| Volatility (annualized) | 27.4% | 32.8% |
| Max drawdown | -14.7% (Dec 2025→Jan 2026) | -55.4% (Nov 2021→Jul 2022) |

## Peers (Insurance - Reinsurance)
HG (Hamilton Insurance Group, Ltd.) USD 37.11 +1.62% · RNR (RenaissanceRe Holdings Ltd.) USD 362.59 +2.12% · EG (Everest Group, Ltd.) USD 407.56 +3.24% · RGA (Reinsurance Group of America, I) USD 272.05 +1.07% · GLRE (Greenlight Reinsurance, Ltd.) USD 15.3 +2.41%

## More
Full page: https://nexqual.com/SPNT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in SPNT's own 10-K filed 2026-02-24 (https://www.sec.gov/Archives/edgar/data/1576018/000157601826000032/spnt-20251231.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Arcadian Risk Capital | "On October 3, 2025, we entered into an agreement to sell our 49% equity stake in Arcadian to Lee Equity Partners for total consideration of $140.4 million, inclusive of a pre-close dividend." |
| Partner | ArmadaCorp Capital | "We will continue our underwriting capacity partnership with Armada until the end of 2030." |

## Company outlook (8-K filed 2026-07-29)

- "In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "believes," "intends," "seeks," "anticipates," "aims," "plans," "targets," "estimates," "expects," "assumes," "continues," "guidance," "should," "could," "will," "may" and the negative of these or similar terms and phrases."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.64 | $0.58 | +10.2% | $783.1M | 5 |
| Next quarter (ends 2026-12-31) | $0.61 | $0.61 | -0.7% | $787.4M | 5 |
| Current fiscal year (ends 2026-12-31) | $2.66 | $2.57 | +3.6% | $3.09B | 5 |
| Next fiscal year (ends 2027-12-31) | $2.76 | $2.77 | -0.2% | $3.26B | 5 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2027-01-15 (includes earnings 2026-11-05): ±11.7%; last 8 reports averaged ±4.3%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2027-01-15 | 84 | 30.3% | ±11.7% |
| 2027-04-16 | 175 | 30.0% | ±16.5% |